Skip to main content
Premium Trial:

Request an Annual Quote

Genentech Subscribes to Gene Logic s BioExpress Database

NEW YORK, Feb 15 - Gene Logic said Thursday that Genentech subscribed to its BioExpress database, making Genetech the seventh customer for BioExpress.

Financial terms of the multi-year subscription were not disclosed, but Gene Logic has said previously that subscriptions are typically for three years and can cost up to $4 million per year for pharmaceutical companies and $2 million a year for biotechs.

The BioExpress database contains gene expression information for normal and diseased human tissues, tissues from model animal systems, and human and animal cell lines for use in drug target identification.

In addition to BioExpress, Gene Logic sells subscriptions to ToxExpress, which offers data on the effects of more than 10 toxic compounds on the liver, kidney, bone marrow, and heart of animals. The company has eight subscribers for this database.

GeneLogic of Gaithersburg, Md., is also planning to launch in 2001 a new database, PharmExpress, which will offer information about the effect pharmaceuticals have on gene expression.

Genetech also subscribes to Incyte Genomics databases.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.